Michael Gregory Buhnerkempe
8PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 26, 2026
SGLT-2 inhibitors in prevention of chemotherapy-induced cardiotoxicity: systematic review and meta-analysis.Soomal Rafique, Michael Buhnerkempe, Yansoun Elmasry
|Aug 14, 2025
Expanding the Search for Primary Aldosteronism in Clinical Settings.John M Flack, Michael G Buhnerkempe, Garry L R Jennings
|May 06, 2024
Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection.Michael G Buhnerkempe, Stephanie Bitner, John M Flack
|Feb 16, 2024
Resistant Hypertension: Disease Burden and Emerging Treatment Options.John M Flack, Michael G Buhnerkempe, Kenneth Todd Moore
|Jan 12, 2022
Race and Antihypertensive Drug Therapy: Edging Closer to a New Paradigm.John Mark Flack, Michael Gregory Buhnerkempe
Pageof 2
Frequent Collaborators
4 joint publications
John Mark Flack
1 joint publications
Soomal Rafique
1 joint publications
Sarah K Helman
1 joint publications
Riley O Mummah
1 joint publications
Katelyn M Gostic
1 joint publications
Katherine C Prager
1 joint publications
James O Lloyd-Smith
1 joint publications
Kenneth Todd Moore
1 joint publications
Garry L R Jennings
1 joint publications
James Brian Byrd
